| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |